Navigation Links
PRA International Rolls out Client Access to Oracle(R) RDC for Early Phase Studies
Date:1/15/2010

RALEIGH, N.C., Jan. 15 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that it will begin providing a client-facing portal into Oracle® Remote Data Capture (RDC) for its early phase studies in its Clinical Pharmacology Units in The Netherlands and the United States. Through the portal, clients working with PRA will have direct access to review RDC data. The portal provides sponsors with the ability to review all entered data, to move between subjects and pages, to see the multiple page views within the system and to compare separate pages in a side-by-side fashion.

Perhaps the most important benefit from this application is improved efficiency in study monitoring. A study monitor can monitor remotely either as a replacement for some site visits or to review data ahead of time in preparation for a site visit. This results in higher quality data and lower study costs through the reduction of monitoring time and queries. Other benefits from this system include the potential for increased client visibility into any potential safety concerns (via live data review) and enhanced communication regarding potential data issues between the client and PRA.

PRA's Early Development Services (EDS) group provides comprehensive services for phase I and phase IIa studies in healthy volunteers or special patient populations. Our expertise is primarily with more complex types of studies in which safety and intelligent design are critical factors.

About PRA International

PRA International conducts clinical trials in more than 75 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in oncology, neurosciences, respiratory/allergy, cardiovascular and infectious diseases. PRA has supported over 2,100 clinical trials through its 36+ global offices.

PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA International

RELATED LINKS
http://www.prainternational.com

'/>"/>

SOURCE PRA International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. On Call International Opens Haiti Earthquake Emergency Hotline
2. International SOS and MediSend to Partner on Humanitarian Healthcare
3. Flu Shots Now Offered in Los Angeles International Airport Terminals
4. Statement by Blue Shield of California CEO Bruce Bodaken Regarding the Groundbreaking for the Family Violence Prevention Funds International Center
5. International Isotopes Inc. Announces Submission of the License Application for Their Uranium De-conversion and Fluorine Extraction Processing Facility
6. PharmaSmart International, Inc and AstraZeneca Canada Enter Into Strategic Partnership to Elevate Pharmacy Based Hypertension Management
7. AHD International & Funktional Beverages, Inc Launch Red Stuff™ with LuraLean
8. American University of Antigua Becomes First International School to Administer Web-Based NBME Exam
9. Jamie Oliver, Chef and International Nutrition Advocate, Named Recipient of 2010 TED Prize
10. Reliv Internationals Carl W. Hastings Elected to Board of the Council for Responsible Nutrition
11. Orameds Dr Roy Eldor was Chosen to Lecture at the First International Conference Held by the Bildirici Center for Diabetes Care Research in Israel.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... , media relations, content marketing, social media management, corporate communications, SEO and cause ... the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus ...
(Date:2/23/2017)... Colorado (PRWEB) , ... February 23, 2017 , ... ... Magazine, an exciting, new, interactive publication where generations converge and explore the world ... expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... new partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) ... for children with autism spectrum disorder (ASD) to see films in an environment ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... York (PRWEB) , ... February 22, 2017 , ... ... entrance and lobby of a new healthcare contact center in Georgia, PENETRON Specialty ... One of the nation’s largest healthcare systems recently invested $51 million to purchase ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017  Cogentix Medical, Inc. ... and markets innovative proprietary products for the urology market, ... fiscal year ended December 31, 2016 before the market ... The Company will host a conference call and webcast ... Thursday, March 9, 2017 at 11:00 a.m. Eastern Time ...
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has announced ... 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - ... The research answers the following questions: ... How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price ... in the global Fibromyalgia market. The research answers the ... marketed for Fibromyalgia and their clinical attributes? How are they positioned ...
Breaking Medicine Technology: